The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A
Abstract
β-Adrenergic receptor (βAR) signaling, which elevates intracellular cAMP and enhances cardiac contractility, is severely impaired in the failing heart. Protein kinase A (PKA) is activated by cAMP, but the long-term physiological effect of PKA activation on cardiac function is unclear. To investigate the consequences of chronic cardiac PKA activation in the absence of upstream events associated with βAR signaling, we generated transgenic mice that expressed the catalytic subunit of PKA in the heart. These mice developed dilated cardiomyopathy with reduced cardiac contractility, arrhythmias, and susceptibility to sudden death. As seen in human heart failure, these abnormalities correlated with PKA-mediated hyperphosphorylation of the cardiac ryanodine receptor/Ca 2+ -release channel, which enhances Ca 2+ release from the sarcoplasmic reticulum, and phospholamban, which regulates the sarcoplasmic reticulum Ca 2+ -ATPase. These findings demonstrate a specific role for PKA in the pathogenesis of heart failure, independent of more proximal events in βAR signaling, and support the notion that PKA activity is involved in the adverse effects of chronic βAR signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Phosphorylation-Dephosphorylation of Enzymes
Krebs, E. G., & Beavo, J. A. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.004423 · Cited by 2,205
PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)
Marx, S. O., Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N., & Marks, A. R. (2000) · Cell · doi:10.1016/s0092-8674(00)80847-8 · Cited by 1,978
Self-citationUngerer, M., Böhm, M., Elce, J. S., Erdmann, E., & Lohse, M. J. (1993) · Circulation · doi:10.1161/01.cir.87.2.454 · Cited by 878
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein
Brillantes, A.-M. B., Ondrias, K., Scott, A., Kobrinsky, E., Ondriašová, E., Moschella, M. C., Jayaraman, T., Landers, M., Ehrlich, B. E., & Marks, A. R. (1994) · Cell · doi:10.1016/0092-8674(94)90214-3 · Cited by 827
Self-citationProgressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic mice
Engelhardt, S., Hein, L., Wiesmann, F., & Lohse, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7059 · Cited by 785
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994) · Science · doi:10.1126/science.8160017 · Cited by 740
Theory of excitation-contraction coupling in cardiac muscle
Stern, M. D. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81615-6 · Cited by 651
Rybin, V. O., Xu, X., Lisanti, M. P., & Steinberg, S. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006951200 · Cited by 520
Minamisawa, S., Hoshijima, M., Chu, G., Ward, C. A., Frank, K., Gu, Y., Martone, M. E., Wang, Y., Ross, J., Kranias, E. G., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81662-1 · Cited by 506
Cited by
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Self-citationAtrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Nattel, S., Burstein, B., & Dobrev, D. (2008) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.107.754564 · Cited by 1,124
What Is the Role of β-Adrenergic Signaling in Heart Failure?
Lohse, M. J., Engelhardt, S., & Eschenhagen, T. (2003) · Circulation Research · doi:10.1161/01.res.0000102042.83024.ca · Cited by 764
Zhang, T., Maier, L. S., Dalton, N. D., Miyamoto, S., Ross, J., Bers, D. M., & Brown, J. H. (2003) · Circulation Research · doi:10.1161/01.res.0000069686.31472.c5 · Cited by 556
Multiple Facets of NF-κB in the Heart: To Be or Not to NF-κB
Gordon, J. W., Shaw, J. A., & Kirshenbaum, L. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.226928 · Cited by 551
Lehnart, S. E., Wehrens, X. H. T., Reiken, S., Warrier, S., Belevych, A. E., Harvey, R. D., Richter, W., Jin, S.-L. C., Conti, M., & Marks, A. R. (2005) · Cell · doi:10.1016/j.cell.2005.07.030 · Cited by 517
Self-citationActivated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Self-citationPatrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S. D., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.017 · Cited by 468
Calcium cycling proteins and heart failure: mechanisms and therapeutics
Marks, A. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62834 · Cited by 402
Self-citationNeef, S., Dybkova, N., Sossalla, S., Ort, K. R., Fluschnik, N., Neumann, K., Seipelt, R., Schöndube, F. A., Hasenfuss, G., & Maier, L. S. (2010) · Circulation Research · doi:10.1161/circresaha.109.203836 · Cited by 399
Hoshijima, M., Ikeda, Y., Iwanaga, Y., Minamisawa, S., Date, M.-O., Gu, Y., Iwatate, M., Li, M., Wang, L., Wilson, J. M., et al. (2002) · Nature Medicine · doi:10.1038/nm739 · Cited by 373
Fischmeister, R., Castro, L. R. V., Abi-Gerges, A., Rochais, F., Jurevičius, J., Leroy, J., & Vandecasteele, G. (2006) · Circulation Research · doi:10.1161/01.res.0000246118.98832.04 · Cited by 367
Sadana, R., & Dessauer, C. W. (2009) · Neurosignals · doi:10.1159/000166277 · Cited by 361
miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy
Lin, Z., Murtaza, I., Wang, K., Jiao, J., Gao, J., & Li, P.-F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811371106 · Cited by 359
INTRACELLULAR CALCIUM RELEASE AND CARDIAC DISEASE
Wehrens, X. H. T., Lehnart, S. E., & Marks, A. R. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.114521 · Cited by 355
Self-citationType 5 Adenylyl Cyclase Disruption Increases Longevity and Protects Against Stress
Yan, L., Vatner, D. E., O'Connor, J. P., Ivessa, A., Ge, H., Chen, W., Hirotani, S., Ishikawa, Y., Sadoshima, J., & Vatner, S. F. (2007) · Cell · doi:10.1016/j.cell.2007.05.038 · Cited by 353
Calmodulin-Dependent Protein Kinase II: Linking Heart Failure and Arrhythmias
Swaminathan, P. D., Purohit, A., Hund, T. J., & Anderson, M. E. (2012) · Circulation Research · doi:10.1161/circresaha.111.243956 · Cited by 283
Molecular Determinants of Altered Ca 2+ Handling in Human Chronic Atrial Fibrillation
El-Armouche, A., Boknik, P., Eschenhagen, T., Carrier, L., Knaut, M., Ravens, U., & Dobrev, D. (2006) · Circulation · doi:10.1161/circulationaha.106.636845 · Cited by 274
Mitochondria in cardiac hypertrophy and heart failure
Rosca, M. G., Tandler, B., & Hoppel, C. L. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.09.002 · Cited by 267
Gorski, P. A., Ceholski, D. K., & Hajjar, R. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.005 · Cited by 213
“Nevertheless, the mechanism of PKA-mediated hyperphosphorylation of RyR2 during heart failure is under debate, as several studies reported RyR2 channel activity to be slightly decreased in response to phosphorylation (Valdivia et al., 1995; Xiao et al., 2005).”
InfluentialIsoform Selectivity of Adenylyl Cyclase Inhibitors: Characterization of Known and Novel Compounds
Brand, C. S., Hocker, H. J., Gorfe, A. A., Cavasotto, C. N., & Dessauer, C. W. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208157 · Cited by 87
Ho, D., Yan, L., Iwatsubo, K., Vatner, D. E., & Vatner, S. F. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9183-5 · Cited by 68
“published the results on transgenic mice with PKA Ca overexpression, and found the activity of PKA to be elevated, and this was associated with dilated cardiomyopathy, heart failure and increased risk of sudden death, further supporting the adverse effects of chronic b-AR stimulation and PKA activation [127].”
BackgroundFerreira, J. P., Saraiva, F., Sharma, A., Vasques‐Nóvoa, F., Angélico‐Gonçalves, A., Leite, A. R., Borges‐Canha, M., Carvalho, D., Packer, M., Zannad, F., et al. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14997 · Cited by 65
Metadata
- Authors
- Antos, C. L., Frey, N., Marx, S. O., Reiken, S., Gaburjakova, M., Richardson, J. A., Marks, A. R., & Olson, E. N.
- Venue
- Circulation Research
- Published
- 2001-11-23
- Volume
- 89
- Issue
- 11
- Pages
- 997-1004
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2114196012
- Cited by
- 278
- References
- 45
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.